Navigation Links
SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies
Date:3/11/2010

PORTLAND, Ore. and SAN FRANCISCO, March 11 /PRNewswire/ -- SiteJabber.com, a leading consumer protection service which helps people avoid fraudulent websites and find good sites, and LegitScript.com, the world's largest online pharmacy verification program, have announced a partnership to help Internet users better identify trustworthy prescription drug websites and avoid fraudulent ones.

LegitScript, founded in 2007, is identified by the National Association of Boards of Pharmacy (NABP) as the only independent online pharmacy verification program adhering to the NABP's standards. The company has classified over 35,000 prescription drug Web sites as "rogue" and approved over 300 Internet pharmacies as legitimate, including human and veterinary Internet pharmacies.

SiteJabber.com, founded in 2008, is dedicated to helping consumers avoid fraudulent websites and find ones they will love through community reviews. SiteJabber's goal is to improve online transparency and make the Internet a better place for all consumers.  

The agreement between the two companies will give SiteJabber.com visitors information about whether LegitScript has approved a prescription drug Web site as legitimate or designated it as "rogue" (acting in violation of drug safety laws, such as the sale of counterfeit drugs). Meanwhile, visitors to LegitScript.com will be able to take advantage of SiteJabber.com's user interface to rate and share positive and negative information about legitimate and illicit Internet prescription drug websites.

Jeremy Gin, Co-Founder of SiteJabber.com, commented: "For consumers, determining the legality and trustworthiness of online pharmacies can be next to impossible. We at SiteJabber are excited to bring the hundreds of thousands of consumers who visit SiteJabber.com every month the useful insights on online pharmacies provided by LegitScript."  

John Horton, President of LegitScript.com, said: "Internet users are a tremendously important source of information about whether a website meets our standards, or is acting fraudulently and unsafely. Partnering with companies like SiteJabber.com gives our users an additional voice in helping to keep the Internet safe."

The companies indicated that the information-sharing functionality regarding websites identified as legitimate Internet pharmacies has been completed. The additional information-sharing component regarding rogue prescription drug Web sites is slated for completion in April 2010.

SOURCE LegitScript.com; SiteJabber.com

Back to top

RELATED LINKS
http://www.legitscript.com
http://www.sitejabber.com

'/>"/>

SOURCE LegitScript.com; SiteJabber.com
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Robbins & Myers to Release Second Quarter Fiscal 2010 Financial Results
2. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
3. Smith & Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System
4. Blizzard, McCarthy & Nabers Launches ReglanJustice.com
5. International Growth Continues: Rhythmlink International, LLC Receives CE Marking & ISO 13485 Certification
6. Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
7. P&M Corporate Finance and Robin Young Announce 2010 Spine Technology Summit
8. 2nd Annual Orthopedic Design & Technology Forum Returns April 28 to the FedEx Institute of Technology, University of Memphis
9. TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers
10. UBM Announces Plans for Japan Pharma & Bio Events
11. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... DUBLIN , May 26, 2017  Endo International plc ... Campanelli , President and CEO, will represent the Company in ... Global Healthcare Conference on Tuesday, June 13, 2017 at 10:40 ... held at Terranea Resort in Rancho Palos Verdes, ... archive for the event will be available on the Company,s ...
(Date:5/24/2017)... HAMPTON, Va. , May 24, 2017 /PRNewswire/ ... ivWatch Original Equipment Manufacturer (OEM) Board to enable ... technology with patient monitoring systems, infusion pumps and ... products, OEMs will be able to help health ... care and reduced risks related to IV therapy. ...
(Date:5/22/2017)... 22, 2017  Lilac Corp, the company that ... launch of a new website . The ... a clinical study that showed surprising clearance of ... in individuals suffering from HPV warts, precancerous, or ... are no other treatments that clear the virus. ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s Aresty ... executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... University of Pennsylvania campus, followed by the two-day convention, which will target C-suite ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the ... two year study conducted by the University of Saskatchewan in partnership with PotashCorp, ... potash brine-impacted groundwater. As a part of the study, batch adsorption experiments were ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... consultations to communities in northern Virginia and DC, is announcing a cooperative charity ... patients with Alzheimer’s and other disorders that lead to memory impairment. , The ...
(Date:6/27/2017)... IL (PRWEB) , ... June 27, 2017 , ... ... considering a cosmetic treatment, according to survey data released today by the ... on Cosmetic Dermatologic Procedures indicates the percentage of consumers considering a cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
Breaking Medicine News(10 mins):